Update on persistent symptoms associated with Lyme disease

Current Opinion in Pediatrics

Volumn 27, Issue 1, 2015, Pages 100-104

  Oliveira, Carlos R ^a   Shapiro, Eugene D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lyme disease; post treatment Lyme disease syndrome; xenodiagnosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; VIRULENCE FACTOR;

ANTIBIOTIC THERAPY; BORRELIA BURGDORFERI; BORRELIA INFECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DISEASE ASSESSMENT; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LONG TERM CARE; LYME DISEASE; NONHUMAN; PRIORITY JOURNAL; REINFECTION; RELAPSE; REVIEW; XENODIAGNOSIS; ADOLESCENT; CHILD; COMPLICATION; GLOSSITIS, BENIGN MIGRATORY; MICROBIOLOGY; PATHOGENICITY; PRESCHOOL CHILD; UNITED STATES;

ADOLESCENT; ANTI-INFECTIVE AGENTS; BORRELIA BURGDORFERI; CHILD; CHILD, PRESCHOOL; GLOSSITIS, BENIGN MIGRATORY; HUMANS; LYME DISEASE; UNITED STATES; VIRULENCE FACTORS;

EID: 84921617634     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000167     Document Type: Review

References (22)

1. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmo-sis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43:1089-1134
2. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morbid Mortal Weekly Rep 1995; 44:590-591
3. Feder HM Jr, Johnson BJ, OConnell S, et al. A critical appraisal of chronic Lyme disease. N Engl J Med 2007; 357:1422-1430
4. Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti-Infect Ther 2014; 12:1103-1135
5. Klempner MS, Baker PJ, Shapiro ED, et al. Treatment trials for post-Lyme disease symptoms revisited. Am J Med 2013; 126:665-669
6. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984; 57:521-525
7. Picken MM, Picken RN, Han D, et al. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis. Mol Path 1997; 50:186-193
8. Schwartz I, Wormser GP, Schwartz JJ, et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol 1992; 30:3082-3088
9. Wormser GP, Forseter G, Cooper D, et al. Use of a novel technique of cutaneous lavage for diagnosis of Lyme disease associated with erythema migrans. J Am Med Assoc 1992; 268:1311-1313
10. Marques AR, Stock F, Gill V. Evaluation of a new culture medium for Borrelia burgdorferi. J Clin Microbiol 2000; 38:4239-4241
11. Embers ME, Barthold SW, Borda JT, et al. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. Plos One 2012; 7:e29914
12. Wormser GP, Schwartz I. Antibiotic treatment of animals infected with Borrelia burgdorferi. Clin Microbiol Rev 2009; 22:387-395
13. Sapi E, Pabbati N, Datar A. Improved culture conditions for the growth and detection of Borrelia from human serum. Int J Med Sci 2013; 10:362-376
14. Johnson BJ, Pilgard MA, Russell TM. Assessment of new culture method for detection of Borrelia species from serum of Lyme disease patients. J Clin Microbiol 2014; 52:721-724
15. Nelson C, Hojvat S, Johnson B, et al. Concerns regarding a new culture method for Borrelia burgdorferi not approved for the diagnosis of Lyme disease. MMWR Morb Mortal Weekly Rep 2014; 63:333
16. Marques A, Telford SR 3rd, Turk SP, et al. Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study. Clin Infect Dis 2014; 58:937-945
17. Shih CM, Chao LL, Yu CP. Chemotactic migration of the Lyme disease spirochete (Borrelia burgdorferi) to salivary gland extracts of vector ticks. Am J Trop Med Hyg 2002; 66:616-621
18. Bockenstedt LK, Mao J, Hodzic E, et al. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J Infect Dis 2002; 186:1430-1437
19. Li X, McHugh GA, Damle N, et al. Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or Lyme arthritis. Arth Rheum 2011; 63:2238-2247
20. Wormser GP, Nadelman RB, Schwartz I. The amber theory of Lyme arthritis: initial description and clinical implications. Clin Rheum 2012; 31:989-994
21. Nadelman RB, Hanincova K, Mukherjee P, et al. Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med 2012; 367:1883-1890
22. Khatchikian CE, Nadelman RB, Nowakowski J, et al. Evidence for strain-specific immunity in patients treated for early Lyme disease. Infect Immun 2014; 82:1408-1413